StonvexLoading…
StonvexStonvexStonvexCore line items from CGEM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 | Q1 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $144.65M | $177.26M | $207.02M | $-32.66M |
Net Income | $111.21M | $138.00M | $162.80M | $-12.10M |
EPS (Diluted) | $2.38 | $2.96 | $3.51 | $-0.27 |
Total Assets | $561.12M | $617.24M | $667.25M | $437.46M |
Total Liabilities | $26.09M | $31.11M | $62.63M | $17.99M |
Cash & Equivalents | $156.15M | $242.66M | $353.56M | $76.12M |
Free Cash Flow OCF − CapEx | $-127.80M | $-101.93M | $-47.33M | $-21.91M |
Shares Outstanding | 45.80M | 45.74M | 45.40M | 44.66M |